Two Sigma Advisers’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76M | Buy |
743,400
+253,000
| +52% | +$939K | 0.01% | 986 |
|
|
2025
Q1 | $1.58M | Buy |
490,400
+364,000
| +288% | +$1.18M | ﹤0.01% | 1254 |
|
|
2024
Q4 | $704K | Buy |
126,400
+103,500
| +452% | +$576K | ﹤0.01% | 1628 |
|
|
2024
Q3 | $248K | Buy |
+22,900
| New | +$248K | ﹤0.01% | 1994 |
|
|
2023
Q4 | – | Sell |
-87,200
| Closed | -$1.11M | – | 2548 |
|
|
2023
Q3 | $1.11M | Sell |
87,200
-25,146
| -22% | -$320K | ﹤0.01% | 1474 |
|
|
2023
Q2 | $2.03M | Buy |
112,346
+12,346
| +12% | +$223K | 0.01% | 1194 |
|
|
2023
Q1 | $1.72M | Buy |
100,000
+77,900
| +352% | +$1.34M | ﹤0.01% | 1348 |
|
|
2022
Q4 | $491K | Buy |
+22,100
| New | +$491K | ﹤0.01% | 1883 |
|